What Key Laboratory Leaders Will Learn at This Week’s 2023 Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management

Apr 24, 2023 | Laboratory Instruments & Laboratory Equipment, Laboratory Management and Operations, Laboratory Resources, Molecular Diagnostics, Genetic Testing, Whole Gene Sequencing, News From Dark Daily, Pathology and Clinical Laboratory Conferences

Executives and pathologists from many of the nation’s most prominent clinical laboratories are on their way to the Crescent City today to share best practices, hear case studies from innovative labs, and network NEW ORLEANS—This afternoon, more than 900 lab CEOs, administrators, and pathologists will convene for the 28th Annual Executive War College on Diagnostics, Clinical Laboratory, and Pathology Management conference. Three topics of great interest will center around adequate lab staffing,...

Efforts to Allow FDA Oversight of Clinical Laboratory-Developed Tests Continue in New Congress

Apr 21, 2023 | Compliance, Legal, and Malpractice, Laboratory Management and Operations, Laboratory News, Laboratory Testing, Pathology and Clinical Laboratory Conferences

The VALID Act has been refiled and the FDA has declared its intent to issue a proposed rule to enable it to oversee LDTs Should the federal Food and Drug Administration (FDA) have the authority to regulate laboratory-developed tests (LDT)? Advocates in favor of this outcome are working to make FDA oversight of LDTs a reality. On March 29, HR.2369—the Verifying Accurate Leading-edge IVCT Development Act of 2023 (VALID Act)—was refiled in the US House of Representatives by Representatives Larry...
;